uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
Levodopa infusion does not decrease the onset of abnormal involuntary movements in parkinsonian rats
Abbott Healthcare Products B.V., Weesp, The Netherlands. (Neurodegenerative Diseases Research Group, Institute of Pharmaceutical Science, School of Biomedical Sciences, King's College London, London, United Kingdom)
Abbott Healthcare Products B.V., Weesp, the Netherlands.
(Neurodegenerative Diseases Research Group, Institute of Pharmaceutical Science, School of Biomedical Sciences,King's College London, London, United Kingdom)
(Neurodegenerative Diseases Research Group, Institute of Pharmaceutical Science, School of Biomedical Sciences,King's College London, London, United Kingdom)
Show others and affiliations
2013 (English)In: Movement Disorders, ISSN 0885-3185, E-ISSN 1531-8257, Vol. 28, no 8, 1072-1079 p.Article in journal (Refereed) Published
Abstract [en]

The short duration of effect of levodopa is linked to pulsatile stimulation of striatal dopamine receptors and dyskinesia induction. However, the recent introduction of intraduodenal (i.d.) infusions and novel oral controlled release formulations of l-dopa may prevent dyskinesia induction and reduce the severity of established involuntary movements. We have compared the effects of twice-daily intraperitoneal (i.p.) administration and daily i.d. infusion of l-dopa on the induction and expression of abnormal involuntary movements in 6-hydroxydopamine (6-OHDA)-lesioned rats. Animals were treated with either twice-daily i.p. administration of l-dopa/carbidopa (7.85/12.5 mg/kg) or an 8-hour i.d. infusion of l-dopa/carbidopa (20/5 mg/mL; infusion rate: 0.04 mL/h) for 14 days, after which treatments were switched between groups and continued for a further 14 days. Pulsatile i.p. administration of l-dopa induced moderate to severe abnormal involuntary movements, which gradually increased in severity over the 14 days, but i.d. infusion of l-dopa induced abnormal involuntary movements of a similar severity. Switching from continuous i.d. to pulsatile i.p. administration of l-dopa continued to provoke severe abnormal involuntary movements expression. Switching from pulsatile i.p. to continuous i.d. l-dopa administration did not alter the peak abnormal involuntary movement severity but tended to reduce their duration. Treatment with less pulsatile l-dopa administration using i.d. infusion does not reduce the risk of the appearance of dyskinesia. By contrast, the duration of established dyskinesia can be reduced by more continuous l-dopa delivery in agreement with clinical experience

Place, publisher, year, edition, pages
2013. Vol. 28, no 8, 1072-1079 p.
Keyword [en]
Parkinson's disease;intraduodenal levodopa infusion;6-OHDA-lesioned rats;AIMs;dyskinesia
National Category
Pharmaceutical Sciences
Identifiers
URN: urn:nbn:se:uu:diva-287793DOI: 10.1002/mds.25218OAI: oai:DiVA.org:uu-287793DiVA: diva2:923467
Available from: 2016-04-26 Created: 2016-04-26 Last updated: 2016-05-16Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full text

Search in DiVA

By author/editor
Papathanou, Maria
In the same journal
Movement Disorders
Pharmaceutical Sciences

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 6 hits
ReferencesLink to record
Permanent link

Direct link